These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16299067)

  • 1. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):88-94. PubMed ID: 15626718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q; Bhat M; Bowen WD; Cheng J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis.
    Kim SH; Won SJ; Mao XO; Ledent C; Jin K; Greenberg DA
    J Pharmacol Exp Ther; 2006 Oct; 319(1):150-4. PubMed ID: 16831955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.
    Carney ST; Lloyd ML; MacKinnon SE; Newton DC; Jones JD; Howlett AC; Norford DC
    J Neuroimmune Pharmacol; 2009 Sep; 4(3):338-49. PubMed ID: 19365734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.
    Chen J; Lee CT; Errico S; Deng X; Cadet JL; Freed WJ
    Brain Res Mol Brain Res; 2005 Apr; 134(2):215-25. PubMed ID: 15836919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.
    Zhuang SY; Bridges D; Grigorenko E; McCloud S; Boon A; Hampson RE; Deadwyler SA
    Neuropharmacology; 2005 Jun; 48(8):1086-96. PubMed ID: 15910885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.
    Blair RE; Deshpande LS; Sombati S; Falenski KW; Martin BR; DeLorenzo RJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1072-8. PubMed ID: 16469864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
    Mendiguren A; Pineda J
    Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.
    Tyler K; Hillard CJ; Greenwood-Van Meerveld B
    Eur J Pharmacol; 2000 Dec; 409(2):207-11. PubMed ID: 11104836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.
    Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
    Neuroscience; 2015 Sep; 303():149-59. PubMed ID: 26135674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabinoids on non-adrenergic non-cholinergic-mediated relaxation in guinea-pig trachea.
    Nieri P; Martinotti E; Testai L; Martinelli C; Breschi MC
    Eur J Pharmacol; 2003 Aug; 475(1-3):115-8. PubMed ID: 12954367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon.
    Storr M; Sibaev A; Marsicano G; Lutz B; Schusdziarra V; Timmermans JP; Allescher HD
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G110-7. PubMed ID: 12893627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures.
    Nagayama T; Sinor AD; Simon RP; Chen J; Graham SH; Jin K; Greenberg DA
    J Neurosci; 1999 Apr; 19(8):2987-95. PubMed ID: 10191316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-NAME (N omega-nitro-L-arginine methyl ester), a nitric-oxide synthase inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a cannabinoid agonist, interact to evoke synergistic hypothermia.
    Rawls SM; Tallarida RJ; Gray AM; Geller EB; Adler MW
    J Pharmacol Exp Ther; 2004 Feb; 308(2):780-6. PubMed ID: 14610231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.